Hanmi Pharm Co Ltd 128940
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₩497,500.00
- Day Range
- ₩492,500.00–507,000.00
- 52-Week Range
- ₩302,000.00–647,000.00
- Bid/Ask
- ₩497,500.00 / ₩506,000.00
- Shares Outstanding
- 12.69M
- Market Cap
- ₩6.42T
- Volume/Avg
- 55,128 / 128,232
Key Statistics
- Price/Earnings (Normalized)
- 29.95
- Price/Sales
- 3.88
- Dividend Yield (Trailing)
- 0.40%
- Dividend Yield (Forward)
- 0.40%
- Dividend Payment Schedule
- Apr
- Total Yield
- 0.40%
Company Profile
Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 2,400
- Website
- http://www.hanmi.co.kr
Valuation
|
Metric
|
128940
|
|---|---|
Price/Earnings (Normalized) | 29.95 |
Price/Book Value | 4.57 |
Price/Sales | 3.88 |
Price/Cash Flow | 16.74 |
Price/Earnings
128940
Financial Strength
|
Metric
|
128940
|
|---|---|
Quick Ratio | 1.15 |
Current Ratio | 1.82 |
Interest Coverage | 20.28 |
Quick Ratio
128940
Profitability
|
Metric
|
128940
|
|---|---|
Return on Assets (Normalized) | 12.74% |
Return on Equity (Normalized) | 21.67% |
Return on Invested Capital (Normalized) | 14.88% |
Return on Assets
128940
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|z&fFg$yQ | LOCK|h%cv | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|&D!<?Bb | LOCK|y$?@> | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|$q&Q#M? | LOCK|fV | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|&@JQkf&t | LOCK|^B | $29B | |||
| Viatris Inc
VTRS
| LOCK|Dn@?!WW | LOCK|!v | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|R^ | LOCK|j!Z | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|p$>?T% | LOCK|@^ | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|$<!Clyq | LOCK|%!y | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|vQ@v#N | LOCK|cDbJ# | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|J<VNHZ | LOCK|?>W | $2B |
United States